
Lisata Therapeutics, Inc.
LSTANasdaqCIK 320017HealthcareFiscal year ends Dec 31
Reports and events: 393 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2024-02-2916:12 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000320017-24-000007 |
| 2024-02-2916:09 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000320017-24-000006 |
| 2023-11-0216:11 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000320017-23-000063 |
| 2023-11-0216:10 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000320017-23-000062 |
| 2023-08-1416:10 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0000320017-23-000055 |
| 2023-08-1416:08 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000320017-23-000054 |
| 2023-07-1116:01 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000320017-23-000037 |
| 2023-06-1417:05 ET | 8-K | 5.07 Shareholder vote results | 0000320017-23-000031 |
| 2023-05-0916:09 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0000320017-23-000028 |
| 2023-05-0916:08 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000320017-23-000027 |
| 2023-05-0116:02 ET | DEF 14A | Proxy statementPeriod 2023-05-01 | 0000320017-23-000022 |
| 2023-05-0116:01 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000320017-23-000021 |
| 2023-03-3016:09 ET | 10-K | Annual reportPeriod 2022-12-31 | 0000320017-23-000011 |
| 2023-03-3016:07 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000320017-23-000010 |
| 2023-02-0616:02 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000320017-23-000003 |
| 2022-11-1016:12 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0000320017-22-000102 |
| 2022-11-1016:10 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000320017-22-000101 |
| 2022-10-1416:01 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001140361-22-037226 |
| 2022-10-0416:42 ET | 8-K/A | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-22-036093 |
| 2022-09-2916:01 ET | 8-K | 8.01 Other events | 0000320017-22-000094 |
| 2022-09-2216:02 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000320017-22-000085 |
| 2022-09-1509:16 ET | 8-K | 2.01 Completion of an acquisition or disposition; 3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-22-033411 |
| 2022-09-1417:01 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0000320017-22-000079 |
| 2022-08-1912:33 ET | 8-K | 3.01 Delisting notice | 0000320017-22-000071 |
| 2022-08-0516:01 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000320017-22-000061 |
| 2022-08-0416:44 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0000320017-22-000057 |
| 2022-05-2316:08 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000320017-22-000046 |
| 2022-05-0516:09 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0000320017-22-000042 |
| 2022-05-0516:07 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000320017-22-000041 |
| 2022-04-2707:05 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000320017-22-000031 |
| 2022-04-2116:04 ET | 10-K/A | Annual report, amendedPeriod 2021-12-31 | 0000320017-22-000025 |
| 2022-03-2216:10 ET | 10-K | Annual reportPeriod 2021-12-31 | 0000320017-22-000016 |
| 2022-03-2216:09 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000320017-22-000015 |
| 2022-02-2516:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000320017-22-000008 |
| 2022-02-1816:47 ET | 8-K | 3.01 Delisting notice | 0000320017-22-000005 |
| 2021-11-0416:12 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0000320017-21-000108 |
| 2021-11-0416:09 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000320017-21-000107 |
| 2021-08-0516:14 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0000320017-21-000100 |
| 2021-08-0516:09 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000320017-21-000099 |
| 2021-06-1616:20 ET | 8-K | 5.07 Shareholder vote results | 0000320017-21-000079 |
| 2021-06-0416:44 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000320017-21-000075 |
| 2021-05-0616:08 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0000320017-21-000067 |
| 2021-05-0616:06 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000320017-21-000066 |
| 2021-04-2816:03 ET | DEF 14A | Proxy statementPeriod 2021-04-28 | 0000320017-21-000056 |
| 2021-03-1917:23 ET | 8-K | 5.01 Change in control; 9.01 Financial statements and exhibits | 0000320017-21-000046 |
| 2021-02-2516:08 ET | 10-K | Annual reportPeriod 2020-12-31 | 0000320017-21-000043 |
| 2021-02-2516:07 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000320017-21-000042 |
| 2021-02-1616:51 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0000320017-21-000032 |
| 2021-01-2907:58 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000320017-21-000009 |
| 2021-01-2516:01 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0000320017-21-000006 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 19:21 ET. Listed shows no prices and gives no investment advice.